Although the Lyme disease spirochete, Borrelia burgdorferi, is difficult to recover from infected human tissues and fluids, we believe it is likely that persistent live spirochetes or spirochetal fragments are driving the illness throughout much of its course. Evidence for this view includes the responsiveness of many patients to antibiotics even after long-term infection, the occasional sightings of spirochetes in affected tissues, the antigen-specific proliferation of lymphocytes from these patients, and time-dependent variations in the antibody responses to spirochetal antigens in some individuals. However, the recovery of spirochetes from infected tissues by culture is only occasionally possible, and in direct methods based on a strong, specific immunological response have so far demonstrated a fundamental lack of sensitivity and specificity. We propose to use the polymerase chain reaction (PCR) as a diagnostic tool for the detection of the Lyme disease spirochete. This ingenious method uses repeated cycles of oligonucleotide-directed DNA synthesis to amplify small numbers of target sequences to detectable levels in a matter of hours. PCR can be used to search for a genetic needle in a genomic DNA haystack, precisely the mission required for the direct detection of B. burgdorferi in human clinical samples. However, with new and powerful methods come problems of an equal magnitude. The greatest asset of PCR, high sensitivity, is tempered by a dangerous predilection for producing false positives, made worse because the products of the reaction itself (amplicons) may serve as carried-over substrates for future reactions. In addition to employing recommended procedures for reducing amplicon carryover, we have addressed this problem by: 1) having results verified in two outside laboratories, 2) employing amplicon sterilization techniques on a regular basis, and 3) using multiple genetic target loci for detection of the organism. Aside from addressing false positives, we feel the latter """"""""multi-locus"""""""" approach will be extremely useful for highlighting genetic differences between spirochetal isolates from different geographic areas, and even more importantly, for avoiding false negative results due to such differences when these methods are used on infected tissues. Thus, having set the stage with sterilization techniques and multiple genetic targets, and armed with preliminary data from old ticks, old (and young) mice, and human clinical specimens, we are equipped to proceed with large-scale, multi- center clinical and prospective trials of this diagnostic technology for the detection of B. burgdorferi in humans.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI032403-01
Application #
3147455
Study Section
Special Emphasis Panel (SRC (70))
Project Start
1991-09-30
Project End
1996-08-31
Budget Start
1991-09-30
Budget End
1992-08-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Krause, Peter J; Foley, Daniel T; Burke, Georgine S et al. (2006) Reinfection and relapse in early Lyme disease. Am J Trop Med Hyg 75:1090-4
Lodes, M J; Mohamath, R; Reynolds, L D et al. (2001) Serodiagnosis of human granulocytic ehrlichiosis by using novel combinations of immunoreactive recombinant proteins. J Clin Microbiol 39:2466-76
Hofmeister, E K; Glass, G E; Childs, J E et al. (1999) Population dynamics of a naturally occurring heterogeneous mixture of Borrelia burgdorferi clones. Infect Immun 67:5709-16
Hofmeister, E K; Kolbert, C P; Abdulkarim, A S et al. (1998) Cosegregation of a novel Bartonella species with Borrelia burgdorferi and Babesia microti in Peromyscus leucopus. J Infect Dis 177:409-16
Jahangir, A; Kolbert, C; Edwards, W et al. (1998) Fatal pancarditis associated with human granulocytic Ehrlichiosis in a 44-year-old man. Clin Infect Dis 27:1424-7
Krause, P J; Spielman, A; Telford 3rd, S R et al. (1998) Persistent parasitemia after acute babesiosis. N Engl J Med 339:160-5
Zhang, Y Q; Mathiesen, D; Kolbert, C P et al. (1997) Borrelia burgdorferi enzyme-linked immunosorbent assay for discrimination of OspA vaccination from spirochete infection. J Clin Microbiol 35:233-8
Kolbert, C P; Bruinsma, E S; Abdulkarim, A S et al. (1997) Characterization of an immunoreactive protein from the agent of human granulocytic ehrlichiosis. J Clin Microbiol 35:1172-8
Tang, Y W; Espy, M J; Persing, D H et al. (1997) Molecular evidence and clinical significance of herpesvirus coinfection in the central nervous system. J Clin Microbiol 35:2869-72
Persing, D H (1997) The cold zone: a curious convergence of tick-transmitted diseases. Clin Infect Dis 25 Suppl 1:S35-42

Showing the most recent 10 out of 46 publications